Developing the Stentrode, an endovascular, minimally invasive BCI implant enabling paralyzed individuals to control digital devices using thought alone.
Synchron is the leading endovascular BCI company, differentiated by the Stentrode’s ability to reach the brain without open-skull surgery. This minimally invasive route gives it one of the clearest practical advantages in the assistive BCI field, even if bandwidth is lower than intracortical systems.
.svg)
.jpeg)
